Free Trial

Jushi (OTCMKTS:JUSHF) Stock Price Up 12.8% - Here's What Happened

Jushi logo with Medical background

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report)'s stock price traded up 12.8% during trading on Tuesday . The company traded as high as $0.32 and last traded at $0.31. 296,578 shares traded hands during trading, an increase of 14% from the average session volume of 260,810 shares. The stock had previously closed at $0.28.

Analyst Ratings Changes

Separately, Atb Cap Markets cut shares of Jushi from a "hold" rating to a "strong sell" rating in a research note on Monday, December 9th.

View Our Latest Analysis on Jushi

Jushi Price Performance

The firm has a market cap of $61.15 million, a price-to-earnings ratio of -1.15 and a beta of -1.22. The stock has a 50-day moving average of $0.36 and a 200-day moving average of $0.49.

Jushi (OTCMKTS:JUSHF - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.04). Jushi had a negative return on equity of 5,529.11% and a negative net margin of 20.93%. The company had revenue of $61.61 million during the quarter, compared to the consensus estimate of $65.53 million. On average, equities analysts expect that Jushi Holdings Inc. will post -0.23 EPS for the current fiscal year.

About Jushi

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
GameStop’s Cash Pile Grows: Will This Be Enough to Save the Company?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines